Inventor · disambiguated record
Stanford Peng
Also filed as: PENG STANFORD · PENG STANFORD L · PENG STANFORD LEE-YU
5 granted patents·14 pending applications·4 citations·filing 2007–2024
73Inventor score
Top patents by PatentIndex Score
19 records- 0193US11274140B2APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Mar 15, 2022·2 cites·30 claims
- 0290US12304943B2April and BAFF inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2024·Granted May 20, 2025·0 cites·5 claims
- 0385US2025019413A1April and baff inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2024·Application pending·0 cites
- 0485US2025019412A1April and baff inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2024·Application pending·0 cites
- 0582US11202827B2Dosage and administration of non-fucosylated anti-CD40 antibodiesSEAGEN INC·Filed 2017·Granted Dec 21, 2021·2 cites·170 claims
- 0681US2024075134A1Dosage and administration of non-fucosylated anti-cd40 antibodySEAGEN INC·Filed 2023·Application pending·0 cites
- 0781US2024218045A1April and baff inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 0880US2024075135A1Dosage and administration of non-fucosylated anti-cd40 antibodiesSEAGEN INC·Filed 2023·Application pending·0 cites
- 0979US2023201344A1Dosage and administration of non-fucosylated anti-cd40 antibodySEAGEN INC·Filed 2022·Application pending·0 cites
- 1078US2023201343A1Dosage and administration of non-fucosylated anti-cd40 antibodiesSEAGEN INC·Filed 2022·Application pending·0 cites
- 1178US2022265822A1Dosage and administration of non-fucosylated anti-cd40 antibodySEAGEN INC·Filed 2022·Application pending·0 cites
- 1277US2022249662A1Dosage and administration of non-fucosylated anti-cd40 antibodiesSEAGEN INC·Filed 2022·Application pending·0 cites
- 1376US12202882B2APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Jan 21, 2025·0 cites·21 claims
- 1460US11213584B2Dosage and administration of non-fucosylated anti-CD40 antibodiesSEAGEN INC·Filed 2015·Granted Jan 4, 2022·0 cites·46 claims
- 1559US2024279310A1Methods of dosing and treatment with a taci-fc fusion immunomodulatory proteinALPINE IMMUNE SCIENCES INC·Filed 2022·Application pending·0 cites
- 1647US2022177587A1Methods and uses of variant cd80 fusion proteins and related constructsALPINE IMMUNE SCIENCES INC·Filed 2019·Application pending·0 cites
- 1746US2022218785A1Methods and uses of variant icos ligand (icosl) fusion proteinsALPINE IMMUNE SCIENCES INC·Filed 2020·Application pending·0 cites
- 1838US2009099237A1Methods of treating inflammatory diseasesROCHE PALO ALTO LLC·Filed 2008·Application pending·0 cites
- 1936US2008146617A1Methods of treating inflammatory diseasesROCHE PALO ALTO LLC·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →